Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 0

The DOI matches its Crossref record; the references it cites are not checked yet.

From traditional to novel: a national cohort study on the predictive value of C-reactive protein–triglyceride–glucose-obesity composite parameters for cardiovascular disease

Zhao, Mengjie, Wang, Xujie, Zhang, Xuexue, Yan, Yan, Li, Zirong, Lu, Fang, Li, Qiuyan · 2026 · Therapeutic Advances in Endocrinology and Metabolism

Abstract

Background: Cardiovascular disease (CVD) is the leading cause of mortality worldwide. The C-reactive protein–triglyceride–glucose (CTI) index captures metabolic inflammation and insulin resistance, while obesity indices reflect adiposity-related cardiometabolic risk. However, the predictive value of combining CTI with obesity indices for CVD remains unclear. Objectives: To examine the prognostic utility of CTI combined with established and novel obesity indicators for CVD, and to benchmark their predictive efficacy. Design: Nationally representative prospective cohort study. Methods: Using data from the China Health and Retirement Longitudinal Study (CHARLS), a nationally representative prospective cohort, 7847 adults aged 45 years and above without baseline CVD were enrolled. CTI was calculated from C-reactive protein, fasting blood glucose, and triglycerides (TG); each obesity index was combined with CTI to form composite parameters (CTI-body mass index (CTI-BMI), CTI-waist circumference (CTI-WC), CTI-waist-to-height ratio (CTI-WHtR), CTI-body roundness index (CTI-BRI), CTI-weight-adjusted waist index (CTI-WWI), CTI-Chinese visceral adiposity index (CTI-CVAI), CTI-a body shape index (CTI-ABSI)). We employed Cox proportional hazard models, restricted cubic spline analyses, Kaplan–Meier survival plots, ROC curve evaluations, and weighted quantile sum (WQS) regression to examine the links and prognostic utility of each metric with incident CVD across baseline and cumulative exposure tiers. Results: Over a 9-year follow-up period, 1938 new-onset CVD cases were documented. Following multivariable adjustment, each CTI-obesity composite metric showed a significant positive link to CVD risk ( p < 0.05). Moreover, all CTI‑obesity composite parameters showed stronger associations with CVD than CTI alone. CTI‑CVAI demonstrated the relatively best predictive accuracy among the evaluated indices, though absolute discriminatory ability remained modest (baseline area under the ROC curve (AUC): 0.596; cumulative AUC: 0.600). Trajectory clustering found that, versus the well-managed group, the poorly managed subgroup had 21%–71% higher CVD risk (max 71% for CTI-WC). WQS regression indicated that CRP and obesity indices (especially CVAI) were the major contributors in the mixed exposure; cumulative exposure WQS analysis showed that cumulative TG and cumulative obesity parameters contributed the most. Conclusion: CTI combined with obesity indices, particularly CTI-CVAI, was associated with modestly improved predictive ability for CVD risk compared with CTI alone. This parameter may offer incremental information for CVD risk stratification by integrating metabolic inflammation and visceral fat markers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/20420188261471668

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

Research works printed but not linked: 52

  1. 10.1093/qjmed/hcaf022 · DOI
  2. 10.1093/eurjpc/zwae281 · DOI · Paper page
  3. Hu S; National Center for Cardiovascular Diseases—the Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases in China 2023: an updated summary. Biomed Environ Sci 2024; 37(9): 949–992.
  4. 10.1016/j.jacc.2025.08.060 · DOI
  5. 10.26599/1671-5411.2024.04.001 · doi:10.26599/1671-5411.2024.04.001
  6. 10.1177/03000605231164548 · DOI · Paper page
  7. 10.1089/met.2008.0034 · DOI · Paper page
  8. 10.1016/j.compbiomed.2026.111556 · DOI
  9. Yu Y, Yin J, Guo W, et al. Metabolic dysfunction and coronary plaque vulnerability: the predictive role of insulin resistance indices in cardiovascular outcomes. MedComm (2020) 2026; 7(2): e70636.
  10. 10.1016/j.jacc.2025.08.047 · DOI · Paper page
  11. 10.3389/fendo.2022.905266 · DOI · Paper page
  12. 10.1186/s12933-025-02960-w · DOI
  13. 10.1186/s12933-026-03109-z · DOI
  14. 10.1038/s42255-024-01046-3 · DOI
  15. 10.1111/obr.12991 · DOI · Paper page
  16. 10.1016/j.drudis.2021.11.001 · DOI · Paper page
  17. 10.1186/s12933-025-02972-6 · DOI
  18. 10.1093/ije/dys203 · DOI · Paper page
  19. 10.1136/bmj.39335.541782.AD · DOI · Paper page
  20. 10.1093/aje/kwz170 · doi:10.1093/aje/kwz170
  21. 10.1186/s12933-025-02980-6 · DOI
  22. 10.1186/s12933-024-02352-6 · DOI · Paper page
  23. 10.1186/s12933-026-03084-5 · DOI
  24. 10.1001/jama.2017.12126 · DOI · Paper page
  25. 10.1056/NEJMoa1614362 · DOI · Paper page
  26. 10.1016/j.metabol.2021.154766 · DOI · Paper page
  27. 10.1161/CIR.0000000000000973 · DOI · Paper page
  28. 10.2337/dc09-1825 · DOI · Paper page
  29. 10.2337/diacare.29.01.06.dc05-1805 · DOI · Paper page
  30. 10.1038/srep38214 · DOI · Paper page
  31. 10.4093/dmj.2022.0099 · DOI
  32. 10.1186/s12933-020-01095-4 · DOI · Paper page
  33. 10.1007/s11033-026-11509-3 · DOI
  34. 10.1161/01.CIR.91.5.1432 · DOI · Paper page
  35. Record RD, Johnson M, Lee S, et al. Aldosterone and insulin stimulate amiloride-sensitive sodium transport in A6 cells by additive mechanisms. Am J Physiol 1996; 271(4 Pt 1): C1079–C1084. · doi:10.1152/ajpcell.1996.271.4.c1079
  36. 10.1152/ajpcell.00372.2002 · DOI
  37. 10.1093/cvr/cvaa326 · DOI
  38. 10.2147/JIR.S539644 · DOI
  39. 10.1186/s12933-025-03063-2 · DOI
  40. 10.1186/s12933-026-03151-x · DOI
  41. 10.1210/jc.2010-0288 · DOI · Paper page
  42. 10.1186/s12933-023-01819-2 · DOI
  43. 10.1186/s12933-024-02290-3 · DOI
  44. 10.1186/s12944-025-02836-8 · DOI
  45. 10.1016/j.ijcard.2003.08.016 · DOI
  46. 10.1186/s12933-024-02571-x · DOI
  47. 10.1186/s12933-025-02835-0 · DOI
  48. 10.1186/s12933-025-02869-4 · DOI
  49. 10.1186/s12933-026-03132-0 · DOI
  50. 10.1186/s12933-025-03065-0 · DOI
  51. 10.1016/j.numecd.2026.104609 · DOI
  52. 10.1002/dmrr.70109 · DOI

Metadata

Authors
Zhao, M., Wang, X., Zhang, X., Yan, Y., Li, Z., Lu, F., & Li, Q.
Venue
Therapeutic Advances in Endocrinology and Metabolism
Published
2026-03
Volume
17
ISSN
  • 2042-0188
  • 2042-0196
Cited by
0
Language
en
Licence
Funders
  • Objective Research on Four Diagnostic Methods of Traditional Chinese Medicine in Coronary Heart Disease with Blood Stasis Syndrome (BRWEP2024Z014170101)
  • Study on Evaluation Technology System of Herb-Drug Interaction Between Traditional Chinese Medicines and Western Medicines
  • Taking Compound Prescriptions for Activating Blood Circulation to Remove Blood Stasis Combined with Antiplatelet Drugs as an Example (BRWEP2024Z014170102)
  • Evidence-Based Evaluation and Translational Application of Warming Yang and Promoting Blood Circulation Therapy for Chronic Arrhythmia (BRWEP2024Z014170107)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: From traditional to novel: a national cohort study on the predictive value of C-reactive protein–triglyceride–glucose-obesity composite parameters for cardiovascular disease. https://app.cochat.ai/papers/10.1177/20420188261471668
The paper
Zhao, M., Wang, X., Zhang, X., Yan, Y., Li, Z., Lu, F., & Li, Q. (2026). From traditional to novel: a national cohort study on the predictive value of C-reactive protein–triglyceride–glucose-obesity composite parameters for cardiovascular disease. Therapeutic Advances in Endocrinology and Metabolism. https://doi.org/10.1177/20420188261471668

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.